Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines-Reference-Cited by-同舟云学术

Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines

Published:1991-05-10 Issue:2 Volume:48 Page:265-269
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Perez R. P.,O'Dwyer P. J.,Handel L. M.,Ozols R. F.,Hamilton T. C.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cell cycle specific inhibitors

2. and , Computational handbook of statistics, Scott, Foresman Glenview (1987).

3. , , and , Pharmacologic characteristics of carboplatin: clinical experience. In: , and (eds.), Carboplatin: current perspectives and future directions, pp. 19–38, Saunders, Philadelphia (1990).

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of platinum-based anticancer injections cisplatin and carboplatin in blood serum and urine of cancer patients by photometry, fluorometry, liquid chromatography using a Schiff-base as derivatizing reagent;Journal of Pharmaceutical and Biomedical Analysis;2024-01

2. Analysis of platinum-based anticancer injections cisplatin and carboplatin in body fluids blood serum and urine of carcinogenic patients by photometry, fluorometry, liquid chromatography using Schiff-base 2-oxo-propanoic acid- N- phenylhydrazonecarbothioamide as derivatizing reagent;2023-06-28

3. Advancements in the Use of Platinum Complexes as Anticancer Agents;Anti-Cancer Agents in Medicinal Chemistry;2021-08-05

4. Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics;International Journal of Molecular Sciences;2020-09-21

5. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy;Cancer Discovery;2019-05-03